Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Int J Geriatr Psychiatry. 2019 Mar 11;34(5):730–737. doi: 10.1002/gps.5079

Table 1.

Comparisons of the demographics between the Sertraline responder and non-responder groups (two sample t tests on continuous variables and chi-square tests on categorical variables)

Variable Responders (N=15) Non-responders (N=21) P-Value

Age in years mean (±SD) 73.2(±6.71) 73.571(±7.553) 0.87

Female gender, N (%) 10(66.6) 13(61.9) 0.76

Race
 White, N (%) 14(93.3%) 21(100%)
 African American, N (%) 1(6.7%) 0(0%)

Education, years, mean (±SD) 14.9(±3.2) 15.14(±2.3) 0.82

MMSE score (±SD) 29.5(±0.63) 29.3(±1.35) 0.46

MADRS score
 Baseline, mean (SD) 18.67(±5.15) 20.14(±5.6) 0.42
 At 12 weeks, mean (SD) 3.86(±3.1) 12.1(±6.5) 0.005*

Episodes of depression 1, N (%) 2(13.3) 5(23.8)
 More than 1, N (%) 8(53.3) 6(28.5)
 Don’t know/NA, N (%) 3(20%) 9(42.8)
 More than or equal 95, N (%) 2(13.3) 1(4.7)

Mini mental state examination

Montgomery-Asberg Depression Scale

*

Indicates a significant statistical difference with P<.05.